Related Experiment Video

Updated: Aug 19, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Genetic complementation studies using genetically engineered mice have revealed the impact of phospholamban on

S Minamisawa1

  • 1Department of Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University.

Clinical Calcium
|March 19, 2005
PubMed

Insights

Genetic ablation of phospholamban, a SERCA2a inhibitor, rescued dilated cardiomyopathy phenotypes in mice. This suggests targeting phospholamban may be a novel therapeutic strategy for heart failure.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Biochemistry

Context:

  • Dilated cardiomyopathy and end-stage heart failure are associated with impaired calcium (Ca2+) handling in the heart.
  • The sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) is crucial for cardiac muscle relaxation by pumping Ca2+ back into the sarcoplasmic reticulum.
  • Phospholamban regulates SERCA2a activity, and its dysregulation contributes to heart failure pathophysiology.

Purpose:

  • To investigate the role of phospholamban in the pathogenesis of dilated cardiomyopathy.
  • To determine if genetic ablation of phospholamban can ameliorate the cardiac dysfunction observed in a murine model of dilated cardiomyopathy.

Summary:

  • Genetic deletion of phospholamban, an inhibitor of SERCA2a, significantly rescued the diverse phenotypes associated with a mouse model of dilated cardiomyopathy.
  • This rescue indicates that phospholamban's inhibition of SERCA2a is a key factor in the cardiac defects.

Impact:

  • Targeting phospholamban, either through inactivation or by disrupting its interaction with SERCA2a, presents a promising novel therapeutic avenue.
  • This approach could potentially prevent the progression of heart failure and improve cardiac function.

More Related Videos

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes12:49

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes

Published on: September 24, 2013

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...